 |
Code of Federal Regulations (Last Updated: November 8, 2024) |
 |
Title 21 - Food and Drugs |
|
|
Chapter I - Food and Drug Administration, Department of Health and Human Services |
|
|
SubChapter D - Drugs for Human Use |
|
|
Part 343 - Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for over-the-Counter Human Use |
Part 343 - Internal Analgesic, Antipyretic, and Antirheumatic Drug Products for over-the-Counter Human Use
| Subpart A - General Provisions |
| § 343.1 - Scope. |
| § 343.3 - Definitions. |
| Subpart B - Active Ingredients |
| § 343.10 - [Reserved] |
| § 343.12 - Cardiovascular active ingredients. |
| § 343.13 - Rheumatologic active ingredients. |
| § 343.20 - [Reserved] |
| § 343.22 - Permitted combinations of active ingredients for cardiovascular-rheumatologic use. |
| Subpart C - Labeling |
| § 343.50 - [Reserved] |
| §§ 343.50--343.60 - [Reserved] |
| § 343.60 - [Reserved] |
| § 343.80 - Professional labeling. |
| Subpart D - Testing Procedures |
| § 343.90 - Dissolution and drug release testing. |